Stereotactic body radiotherapy (SBRT) for patients with locally advanced pancreatic cancer: A single center experience

In PADC, fractionated SBRT dose schedules near 30 Gy may strike the best balance of local control and bowel toxicity. More work is required to integrate pancreatic SBRT with modern systemic therapy.